Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

http://www.wikidata.org/entity/Q33782706

about

The Possible Role of Antioxidant Vitamin C in Alzheimer's Disease Treatment and Prevention Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer's disease Towards use of MRI-guided ultrasound for treating cerebral vasospasm.Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders The Role of the Craniocervical Junction in Craniospinal Hydrodynamics and Neurodegenerative Conditions H2S- and NO-Signaling Pathways in Alzheimer's Amyloid Vasculopathy: Synergism or Antagonism?The pericyte: a forgotten cell type with important implications for Alzheimer's disease?Heart failure and Alzheimer's disease Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke Impact of age on the cerebrovascular proteomes of wild-type and Tg-SwDI mice Distinct Contributions of Astrocytes and Pericytes to Neuroinflammation Identified in a 3D Human Blood-Brain Barrier on a Chip Disruption of arterial perivascular drainage of amyloid-β from the brains of mice expressing the human APOE ε4 allele Atrial Fibrillation and Risk of Dementia/Cognitive Decline Impaired Aβ clearance: a potential link between atherosclerosis and Alzheimer's disease Immunohistochemical study of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 in the hippocampal vasculature: pathological synergy of Alzheimer's disease and diabetes mellitus Mfsd2a is critical for the formation and function of the blood-brain barrier Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer's disease with combined amyloid-β and cerebrovascular pathology Nonhuman primate models of Alzheimer-like cerebral proteopathy Reduction of circulating endothelial cells in peripheral blood of ALS patients Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice.Intact memory in TGF-β1 transgenic mice featuring chronic cerebrovascular deficit: recovery with pioglitazone Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease.Neurovascular abnormalities in brain disorders: highlights with angiogenesis and magnetic resonance imaging studies.Imaging small vessel-associated white matter changes in aging.Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factors Water Exchange across the Blood-Brain Barrier in Obstructive Sleep Apnea: An MRI Diffusion-Weighted Pseudo-Continuous Arterial Spin Labeling Study.Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions Elevated Aβ42 in aged, non-demented individuals with cerebral atherosclerosis.Vascular pathology in the aged human brain Brain endothelial cells synthesize neurotoxic thrombin in Alzheimer's disease.Model-based physiomarkers of cerebral hemodynamics in patients with mild cognitive impairment.Medullary norepinephrine neurons modulate local oxygen concentrations in the bed nucleus of the stria terminalis.Type 2 diabetes as a risk factor for cognitive impairment: current insights.The potential applications of Apolipoprotein E in personalized medicine Genetic polymorphisms of a novel vascular susceptibility gene, Ninjurin2 (NINJ2), are associated with a decreased risk of Alzheimer's disease.The blood-brain barrier and microvascular water exchange in Alzheimer's disease.Alzheimer's disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs.Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets.Oxidative stress impairs learning and memory in apoE knockout mice.

P2860

Q22241784-BC2E7889-FCA4-45B7-BA16-8A9E06EFF79A Q26753192-FC44C1B5-CDDD-41BF-BEF1-9DB0119BFBD9 Q26765192-7A40C337-03E8-414D-A54E-D605E98C4254 Q26766934-871E57EA-F674-4176-A974-C9BCC132F7A5 Q26771794-D687CAC8-0FDC-466F-9E98-D487E2324F99 Q26773105-BADBC78D-745D-43B9-B66D-FBD49C6AA565 Q26852369-F646D56A-AB25-4CB0-9772-095EA991A6B0 Q26852526-572F78B4-AFDA-4862-88D1-F5A910A8F83C Q26864317-7B0E7182-B853-4146-BED8-91C80E6D2E73 Q27319555-764EA6BB-DC1D-4A30-9901-BDB1D0866AAC Q27319805-2A61EBD3-86F9-4D94-81C9-529DC4B5924D Q27331411-AA23F966-C388-4C2F-9057-5C41E47FE75A Q28074311-4ABE5C98-AB83-4769-8C58-7581A65C78CB Q28082612-EB7390AB-C7FA-457A-B0D0-3A10A0E6D790 Q28269188-2770942C-D85A-46FA-9948-9FB3FE2D771C Q28507996-998EF1A2-35F7-4F06-A63F-C68A2EBB785D Q28594423-877012B2-37A3-4CD2-A7C8-747F11B06553 Q28728135-F6EBC04F-2A88-43B1-9390-74DA60B9F11B Q28752226-A6192C5C-3D74-4122-8960-3D34635B2FD9 Q30495250-CF356F63-3C65-4234-A76A-C2F1769C3909 Q30497417-A38C4EBB-171C-44FC-9F66-7ECC37D5EE87 Q30498345-8F7997A1-8B4E-4F3B-AA1E-15C1774E926C Q30544139-0F66AA88-8A7B-4323-8378-51FD3D451446 Q30653662-230CD513-983C-4BCC-8C53-FF30B1F64DD7 Q30710587-9B839FDA-F908-47EE-A9B3-623C6D6F73FF Q30814231-C90B01AB-55A2-4434-B595-1518EF9F6B9B Q30991175-F7AACCEC-ED2B-4BA0-BAE0-CD3E7DD76AD8 Q30998279-5D46F0F0-3A11-411A-817D-1F7CE638298D Q33697128-33B0456C-C356-4F50-BAC2-AF7E6254B2A1 Q33699436-96C669B6-7FB4-4A21-AD7F-42F7DD4EBD95 Q33745087-82D2938E-1D03-4DA0-BE92-A9064926EEE9 Q33825909-E6C0D4A5-8075-42B4-BB29-6970CB2B9DAB Q33851450-452447DC-A6B2-4B51-BDF4-22D55D2D9808 Q33857774-0C34D323-DC1D-4136-9D70-F92C9D51364F Q33858831-F2688BD4-7BD6-4EC4-BAE6-1042D0FEE244 Q33932945-6C10D376-2B01-4C8A-BF7D-D0A915F6E00C Q33936586-8581B35A-73B5-4423-9F36-1A541862FC73 Q33959032-381879CD-1680-470E-BAD4-4460F2DD7C9B Q33969588-7B72D2A9-F977-42B2-BA89-3E9069DED9F5 Q34044883-6BF1DC48-3161-4EEC-88DA-342EE92EDC91

P2860

Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

http://www.wikidata.org/entity/Q33782706

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

@ast

Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

@en

type

label

Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

@ast

Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

@en

prefLabel

Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

@ast

Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

@en

P1433

Q33782706-92716900-33B4-4C57-B79A-F6105CF0B580

P1476

Q33782706-A99E924C-9DE2-49FF-9926-FA0549BAFD03

P2093

Q33782706-CD4C885C-2746-4A86-880C-76CE5559A0F6

Q33782706-EA4DB747-067C-455E-8812-BFD155097C8C

P2860

Q33782706-0658F7C9-FA9C-4CCD-ADAE-22BC75D10F3B

Q33782706-0A33A972-D59F-4463-A367-93518FDD6114

Q33782706-0C56229A-BB53-4B94-8F4E-2904B1E026C2

Q33782706-0CE4AC10-ECDE-4EF0-970A-9FE232217F42

Q33782706-0DFE5F63-8B58-4CA5-8479-012B5680DD1A

Q33782706-0E02815B-F47C-46F4-AE87-4AA55F1F511C

Q33782706-0FF3153B-6BA3-4F0A-852C-27AEEBB4226F

Q33782706-13662D1D-27A2-413A-B99D-40739F11C0FE

Q33782706-1923E887-EE4F-4F05-A3A9-E049962602CC

Q33782706-1CDCE7EA-5E7F-4A1D-9609-5C03B932653C

P2888

Q33782706-7AF9E9FA-AE7B-4375-9831-7CBDC74D2CC5

P304

Q33782706-2E89602E-960F-4884-A99F-28C7B9950ADD

P31

Q33782706-16F36FCA-E8B1-4066-A230-1903D18FDC64

P356

Q33782706-007379B3-CFFF-4850-BB16-1E7834BD319C

P433

Q33782706-8F01A7D3-4D44-412D-B7D5-3B8ED232A8EF

P478

Q33782706-6C3C6775-C1AF-45E4-A762-5904C6E2CE2E

P577

Q33782706-30A70B3B-EE61-42E2-90FA-F56E407CC46B

P5875

Q33782706-1E689B21-0D9C-4FE1-AC08-4AC6A67E84AC

P6179

Q33782706-6463CF5C-C384-401E-BE5C-461D48384B61

P698

Q33782706-DB8D5D79-FFC5-4ECB-9ABF-DA9BA7DA90D4

P921

Q33782706-E3153C5E-85AB-4D1D-BEA8-C984C37BCAC6

Q33782706-FDF5474F-DAD3-4686-BDE9-09FC3E703806

P932

Q33782706-FF1420FB-26EF-470C-AC71-B417AC3DF7B4

P356

S00401-009-0522-3

P1433

Acta Neuropathologica

P1476

Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

@en

P2093

Berislav V Zlokovic

http://www.w3.org/2001/XMLSchema#string

Robert D Bell

http://www.w3.org/2001/XMLSchema#string

P2860

Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype.

SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells

Interrelationships of the pia mater and the perivascular (Virchow-Robin) spaces in the human cerebrum

Clearance of amyloid-beta by circulating lipoprotein receptors

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

Soluble low density lipoprotein receptor-related protein (LRP) circulates in human plasma

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

Myocardin: a component of a molecular switch for smooth muscle differentiation

P2888

s00401-009-0522-3

P304

103-113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00401-009-0522-3

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24232473

http://www.w3.org/2001/XMLSchema#string

P6179

1049903366

http://www.w3.org/2001/XMLSchema#string

P698

19319544

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

blood–brain barrier

P932

2853006

http://www.w3.org/2001/XMLSchema#string